Huita Wu

Antitumor activity and safety of pembrolizumab in patients with advanced recurrent ovarian cancer: results from the phase II KEYNOTE-100 study

Ursula A. Matulonis, Ronnie Shapira‐Frommer, Alessandro D. Santin et al. · Annals of Oncology · 2019 · 840 citations · Full text

Medicine, Oncology, Pharmacology +15

Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2

Jie Lv, Sheng Zhang, Huita Wu et al. · Cancer Letters · 2019 · 133 citations

Medicine, Cancer Biology, Oncology +14

UBE2C functions as a potential oncogene by enhancing cell proliferation, migration, invasion, and drug resistance in hepatocellular carcinoma cells

Yu Xiong, Jing Lü, Qinliang Fang et al. · Bioscience Reports · 2019 · 73 citations · Full text

Medicine, Molecular Biology, Oncology +11

The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma

Huita Wu, Chengrong Xie, Jie Lv et al. · Laboratory Investigation · 2018 · 42 citations · Full text

Medicine, Cancer Biology, Oncology +17

VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer

Xin Wang, Weiguo Cao, Mingcong Mo et al. · Journal of Surgical Oncology · 2010 · 33 citations

Medicine, Oncology, Pathology +15